• The rector of the UCV, José Manuel Pagán, and the founder and president of the Valencian company, Dr Gabriel Serrano, sign the agreement for the creation of the Sesderma Chair of Cellular Regeneration and Degeneration
• The director of the Chair, José Enrique de la Rubia, assures that it is “a very ambitious project based on humanistic principles to help those who suffer from these diseases”
Valencia, 12 September – The Catholic University of Valencia (UCV) and the Valencian company SESDERMA Laboratories have signed a collaboration agreement for the creation of the Sesderma Chair of Regeneration and Cellular Degeneration. The agreement was sealed by the rector of the UCV, José Manuel Pagán, and the founder and President of Sesderma, Dr Gabriel Serrano, in a ceremony that was also attended by the vice-rector for Research, Francisco Arteaga; the dean of the Faculty of Medicine and Health Sciences, Carlos Barrios; and the director of the new chair, Professor José Enrique de la Rubia.
In the words of De la Rubia himself, the UCV and Sesderma’s commitment is a “very ambitious project based on humanistic principles” that will develop scientific research within the framework of cellular regeneration and neuroprotection “with the aim of helping people who suffer from related pathologies. In this sense, the research work of the chair will cover a wide range of diseases, from those with neurodegenerative origin such as Alzheimer’s, multiple sclerosis or ALS to skin pathologies in which Sesderma, over the last decades, has stood out as a leader in their treatment”.
For all these projects, which are already underway, “one of the most interesting aspects has to be precisely the use of one of Sesderma’s most outstanding technologies: the administration of the different active ingredients in liposomes, which extraordinarily improve the bioavailability and efficacy of the treatments”.
“As a chair, we not only want to carry out research, but we are also clearly aware of the importance of disseminating the new scientific advances we achieve, and of training healthcare professionals through seminars, courses, conferences and congresses. In this sense, another major objective is to develop a master’s degree in neurodegeneration, which would be at the forefront in Spain,” said De la Rubia.
Dr Gabriel Serrano: “Research and innovation are two fundamental pillars of our success”
For his part, Dr Serrano said that the signing of this agreement is “a demonstration of SESDERMA Laboratories’ commitment to the transmission of knowledge” and the “pursuit of excellence” in everything this Valencian company does: “Innovation and scientific research are two fundamental pillars of our company’s success. Together with the experience accumulated over more than thirty years of developing exceptional skincare products, these pillars have enabled us to generate a great deal of knowledge in this field. We also believe that it is important that all this knowledge is passed on to young medical students to help them in their training.
The founder of Sesderma thanked the UCV, “a university with recognised prestige, both inside and outside the Valencian Community”, for wanting to be his “travelling companion” in this project: “Although I am here as president of SESDERMA Laboratories, before a businessman I am a dermatologist, researcher and university professor. That is why I am firmly committed to passing on all the knowledge I have accumulated over my over 45 years of practice to new generations of doctors, especially future dermatologists. And I can think of no better place to do this than this university and its Faculty of Medicine.
